Market Place
Sourcing Support
Chromocell Changes Name to Channel Therapeutics Corporation
21 Nov 2024 //
GLOBENEWSWIRE
Chromocell Unveils Injectable Depot for Surgical Pain Treatment
29 Oct 2024 //
GLOBENEWSWIRE
Chromocell to Present at Upcoming Fall Investor Conferences
28 Oct 2024 //
#N/A
Chromocell Announces Amendment to Stock Repurchase Plan
24 Oct 2024 //
GLOBENEWSWIRE
Chromocell to Present at H.C. Wainwright Global Conference
03 Sep 2024 //
GLOBENEWSWIRE
Chromocell Announces Stock Repurchase Plan
07 Aug 2024 //
GLOBENEWSWIRE
Chromocell to Participate in the Virtual Investor Lunch Break Series
15 Jul 2024 //
GLOBENEWSWIRE
Chromocell To Present At Healthcare Company Showcase On May 21, 2024
13 May 2024 //
GLOBENEWSWIRE
Chromocell Issues Letter to Stockholders from Chief Executive Officer
09 Apr 2024 //
GLOBENEWSWIRE
Chromocell Announces Formal Launch of Eye Pain Treatment Program
21 Mar 2024 //
GLOBENEWSWIRE
Chromocell Names Frank Knuettel as CEO, Removing Interim Status
18 Mar 2024 //
GLOBENEWSWIRE
Chromocell Names Frank Knuettel as CEO
18 Mar 2024 //
GLOBENEWSWIRE
Chromocell to Present at Sidoti Virtual Investor Conference March 13-14
11 Mar 2024 //
GLOBENEWSWIRE
Benuvia Operations and Chromocell Therapeutics Announce Strategic Partnership
27 Feb 2024 //
GLOBENEWSWIRE
Chromocell Announces Closing of Public Offering for Gross Proceeds of $6.6M
21 Feb 2024 //
GLOBENEWSWIRE
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Public Offering
16 Feb 2024 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.